BARRIER THERAPEUTICS INC 4
4 · BARRIER THERAPEUTICS INC · Filed Aug 6, 2008
Insider Transaction Report
Form 4
ALTOMARI ALFRED
DirectorChief Executive Officer
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2008-08-06−370,000→ 0 totalExercise: $3.35Exp: 2018-03-14→ Common Stock (370,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2008-08-06−4,000→ 0 totalExercise: $3.50Exp: 2014-01-19→ Common Stock (4,000 underlying) - Disposition from Tender
Common Stock
2008-08-05$4.15/sh−62,106$257,740→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2008-08-06−75,000→ 0 totalExercise: $1.00Exp: 2013-08-18→ Common Stock (75,000 underlying)
Footnotes (2)
- [F1]Includes 53,750 shares of restricted stock which became fully vested pursuant to the Agreement and Plan of Merger dated June 23, 2008 between Barrier Therapeutics, Inc., Stiefel Laboratories, Inc. and Bengal Acquisition Inc. (the "Merger"). Also includes 1,500 shares purchased on July 31, 2008 pursuant to the Company's Employee Stock Purchase Plan.
- [F2]This option was canceled in connection with the Merger in exchange for the right to receive the difference between the merger consideration of $4.15 per share and the option exercise price.